BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/22/2022 9:38:18 AM | Browse: 859 | Download: 2358
Publication Name World Journal of Clinical Oncology
Manuscript ID 75416
Country Japan
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Pharmacology & Pharmacy
Manuscript Type Retrospective Study
Article Title Necessity of neutrophil-to-lymphocyte ratio monitoring for hypothyroidism using nivolumab in patients with cancer
Manuscript Source Unsolicited Manuscript
All Author List Ako Gannichida, Yusuke Nakazawa, Akira Kageyama, Hirofumi Utsumi, Kazuyoshi Kuwano and Takashi Kawakubo
ORCID
Author(s) ORCID Number
Ako Gannichida http://orcid.org/0000-0002-6981-9386
Yusuke Nakazawa http://orcid.org/0000-0001-9817-2684
Akira Kageyama http://orcid.org/0000-0002-6458-3140
Hirofumi Utsumi http://orcid.org/0000-0003-4845-0599
Kazuyoshi Kuwano http://orcid.org/0000-0003-0551-7386
Takashi Kawakubo http://orcid.org/0000-0002-7403-8226
Funding Agency and Grant Number
Corresponding Author Yusuke Nakazawa, MDS, Assistant Lecturer, Department of Pharmacy, The Jikei University Hospital, 3-19-18 Nishi Shimbashi, Minato-ku, Tokyo 105-8471, Japan, Tokyo 105-8471, Japan. y_nakazawa@jikei.ac.jp
Key Words Nivolumab; Hypothyroidism; Immune checkpoint inhibitors; Immune-related adverse event; Neutrophil-to-lymphocyte ratio
Core Tip This study evaluated whether continuous monitoring of neutrophil-to-lymphocyte ratio (NLR) during nivolumab treatment is useful for predicting the incidence and onset period of hypothyroidism. Patients with hypothyroidism had a significantly lower NLR at treatment initiation, and hypothyroidism incidence was higher among those with NLR < 5. Patients with persistently low NLR (<3.5) developed hypothyroidism earlier than those with an NLR of 3.5 to <5 and ≥5. Low NLR at treatment initiation increases the incidence of treatment-induced hypothyroidism. Furthermore, its persistence may be a risk factor for the early onset of hypothyroidism.
Publish Date 2022-07-22 09:38
Citation Gannichida A, Nakazawa Y, Kageyama A, Utsumi H, Kuwano K, Kawakubo T. Necessity of neutrophil-to-lymphocyte ratio monitoring for hypothyroidism using nivolumab in patients with cancer. World J Clin Oncol 2022; 13(7): 641-651
URL https://www.wjgnet.com/2218-4333/full/v13/i7/641.htm
DOI https://dx.doi.org/10.5306/wjco.v13.i7.641
Full Article (PDF) WJCO-13-641.pdf
Full Article (Word) WJCO-13-641.docx